Showing results (161-170 of 171) with videos related to
Sort By:
Pageof 18
Ophthalmology|January 27, 2024
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO TrialsRamin Tadayoni, Liliana P Paris, Carl J Danzig, et al.Ophthalmology|May 31, 2020
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled StudyDerek Kunimoto, Young Hee Yoon, Charles C Wykoff, et al.The British Journal of Ophthalmology|October 17, 2021
Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomesNeil M Bressler, Miroslav Veith, Jan Hamouz, et al.American Journal of Ophthalmology|July 19, 2022
Plasma Antiretinal Autoantibody Profiling and Diagnostic Efficacy in Patients With Autoimmune RetinopathySeok Hyun Bae, Hye Kyoung Hong, Jong Young Lee, et al.Ophthalmic Surgery, Lasers & Imaging Retina|November 23, 2019
An International Comparison of Baseline Characteristics of Patients Undergoing Initiation of Anti-VEGF Therapy for DMEFelipe F Conti, Arturo Alezzandrini, Chandruganesh Rasendran, et al.Ophthalmology|November 22, 2020
Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular DegenerationRahul N Khurana, Derek Kunimoto, Young Hee Yoon, et al.Ophthalmology|December 29, 2023
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE TrialsTien Y Wong, Zdenka Haskova, Kemal Asik, et al.Clinical Genetics|September 9, 2020
Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCEGo Hun Seo, Taeho Kim, In Hee Choi, et al.Ophthalmology and Therapy|March 28, 2026
Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET StudyKelvin Yi Chong Teo, Young Hee Yoon, Shigeru Honda, et al.Ophthalmology|September 3, 2023
Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter StudyJong G Park, Sean D Adrean, Tedi Begaj, et al.Pageof 18